Julie L. Engers

933 total citations
48 papers, 634 citations indexed

About

Julie L. Engers is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Julie L. Engers has authored 48 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Julie L. Engers's work include Receptor Mechanisms and Signaling (26 papers), Neuroscience and Neuropharmacology Research (25 papers) and Ion channel regulation and function (9 papers). Julie L. Engers is often cited by papers focused on Receptor Mechanisms and Signaling (26 papers), Neuroscience and Neuropharmacology Research (25 papers) and Ion channel regulation and function (9 papers). Julie L. Engers collaborates with scholars based in United States, Denmark and Italy. Julie L. Engers's co-authors include Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender, Max E. Joffe, Kyle A. Emmitte, Anna L. Blobaum, Alice L. Rodriguez, Sichen Chang, J. Scott Daniels and Ryan D. Morrison and has published in prestigious journals such as Neuron, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Julie L. Engers

44 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie L. Engers United States	15	393	367	88	88	71	48	634
Katrin Groebke Zbinden Switzerland	10	504 1.3×	504 1.4×	71 0.8×	78 0.9×	36 0.5×	13	832
Lida Tehrani United States	13	683 1.7×	551 1.5×	124 1.4×	192 2.2×	48 0.7×	19	1.0k
Daniela Alberati Switzerland	16	456 1.2×	358 1.0×	87 1.0×	47 0.5×	51 0.7×	30	806
Philippe Morain France	20	543 1.4×	577 1.6×	98 1.1×	141 1.6×	183 2.6×	33	1.0k
Ryoko Yoshikawa Japan	15	481 1.2×	435 1.2×	54 0.6×	258 2.9×	135 1.9×	19	972
Athanasios Metaxas Denmark	17	263 0.7×	314 0.9×	38 0.4×	35 0.4×	98 1.4×	40	723
Bruce M. Baron United States	20	413 1.1×	439 1.2×	58 0.7×	157 1.8×	47 0.7×	38	967
Christopher Baccei United States	14	411 1.0×	307 0.8×	135 1.5×	81 0.9×	242 3.4×	24	816
Shalini Dogra India	15	285 0.7×	346 0.9×	52 0.6×	19 0.2×	60 0.8×	28	617
Robert P. Compton United States	17	686 1.7×	568 1.5×	140 1.6×	122 1.4×	49 0.7×	25	1.1k

Countries citing papers authored by Julie L. Engers

Since Specialization

Citations

This map shows the geographic impact of Julie L. Engers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie L. Engers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie L. Engers more than expected).

Fields of papers citing papers by Julie L. Engers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie L. Engers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie L. Engers. The network helps show where Julie L. Engers may publish in the future.

Co-authorship network of co-authors of Julie L. Engers

This figure shows the co-authorship network connecting the top 25 collaborators of Julie L. Engers. A scholar is included among the top collaborators of Julie L. Engers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie L. Engers. Julie L. Engers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spearing, Paul K., Sichen Chang, Analisa D. Thompson, et al.. (2025). Discovery of a Novel sp³-Rich M₁ Positive Allosteric Modulators (PAMs) Chemotype via Scaffold Hopping. ACS Medicinal Chemistry Letters. 16(7). 1231–1238.

Engers, Julie L., Changho Han, Alison R. Gregro, et al.. (2025). Application of Deuterium in an M₁ Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422. ACS Chemical Neuroscience. 16(8). 1582–1591.

Chang, Sichen, Krishnan Srinivasan, Olivier Boutaud, et al.. (2025). Total Synthesis and Pharmacological Evaluation of Phochrodines A–C. Journal of Natural Products. 88(4). 996–1003.

Engers, Julie L., Aaron M. Bender, Jonathan W. Dickerson, et al.. (2024). Discovery of VU6007496: Challenges in the Development of an M₁ Positive Allosteric Modulator Backup Candidate. ACS Chemical Neuroscience. 15(18). 3421–3433. 3 indexed citations

Engers, Julie L., Sichen Chang, Vincent B. Luscombe, et al.. (2024). Discovery of VU6008677: A Structurally Distinct Tricyclic M₄ Positive Allosteric Modulator with Improved CYP450 Profile. ACS Medicinal Chemistry Letters. 15(8). 1358–1366. 2 indexed citations

Engers, Julie L., Sichen Chang, Vincent B. Luscombe, et al.. (2024). Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM). ACS Chemical Neuroscience. 1 indexed citations

Spearing, Paul K., Julie L. Engers, Alison R. Gregro, et al.. (2021). Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes – Part 2. Bioorganic & Medicinal Chemistry Letters. 53. 128416–128416. 4 indexed citations

Temple, Kayla J., Julie L. Engers, Sichen Chang, et al.. (2019). Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes. Bioorganic & Medicinal Chemistry Letters. 30(4). 126811–126811. 6 indexed citations

Temple, Kayla J., Julie L. Engers, Alison R. Gregro, et al.. (2019). Discovery of a novel 3,4-dimethylcinnoline carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping. Bioorganic & Medicinal Chemistry Letters. 29(21). 126678–126678. 9 indexed citations

10.

Engers, Julie L., Elizabeth S. Childress, Vincent B. Luscombe, et al.. (2018). VU6007477, a Novel M₁ PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events. ACS Medicinal Chemistry Letters. 9(9). 917–922. 13 indexed citations

11.

Engers, Darren W., Julie L. Engers, Joseph D. Panarese, et al.. (2018). Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liability. Bioorganic & Medicinal Chemistry Letters. 28(15). 2641–2646. 8 indexed citations

12.

Engers, Julie L., Sichen Chang, Xiaoyan Zhan, et al.. (2017). Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping. Bioorganic & Medicinal Chemistry Letters. 27(22). 4999–5001. 14 indexed citations

13.

Felts, Andrew S., Julie L. Engers, Alice L. Rodriguez, et al.. (2017). Design and Synthesis of mGlu₂NAMs with Improved Potency and CNS Penetration Based on a Truncated Picolinamide Core. ACS Medicinal Chemistry Letters. 8(9). 919–924. 31 indexed citations

14.

Joffe, Max E., et al.. (2017). Metabotropic glutamate receptor subtype 3 gates acute stress-induced dysregulation of amygdalo-cortical function. Molecular Psychiatry. 24(6). 916–927. 37 indexed citations

15.

Rook, Jerri M., Masahito Abe, Hyekyung P. Cho, et al.. (2016). Diverse Effects on M₁ Signaling and Adverse Effect Liability within a Series of M₁ Ago-PAMs. ACS Chemical Neuroscience. 8(4). 866–883. 41 indexed citations

16.

Duvernay, Matthew T., M. Schulte, Kellie D. Nance, et al.. (2014). Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354. Bioorganic & Medicinal Chemistry Letters. 24(19). 4708–4713. 29 indexed citations

17.

Sheffler, Douglas J., Cody J. Wenthur, J. Scott Daniels, et al.. (2013). Development of the First Selective mGlu3 NAM from an mGlu5 PAM Hit. Europe PMC (PubMed Central). 3 indexed citations

18.

Wenthur, Cody J., Ryan D. Morrison, Andrew S. Felts, et al.. (2013). Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu₃ Selective and CNS Penetrant Negative Allosteric Modulator (NAM). Journal of Medicinal Chemistry. 56(12). 5208–5212. 47 indexed citations

19.

Niswender, Colleen M., Alice L. Rodriguez, Douglas J. Sheffler, et al.. (2013). Extended Probe Characterization: Development of an M4 PAM with Improved Activity and Brain Exposure, while Avoiding Species Bias.

20.

Thériault, Jimmy R., Andrew S. Felts, José R. Perez, et al.. (2011). Discovery of a new molecular probe ML228: An activator of the hypoxia inducible factor (HIF) pathway. Bioorganic & Medicinal Chemistry Letters. 22(1). 76–81. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact